Pfizer Halts Ranbaxy's Diflucan Generic With Court Ruling
The court’s decision keeps a generic version by Indian drugmaker Ranbaxy Laboratories Ltd. off the market until July 29.
The ruling came in response to a suit filed by the generic manufacturer Ranbaxy contending that its generic version of Diflucan was not subject to the exclusivity period for Pfizer's product.
A previous lawsuit brought by Pfizer against Ranbaxy for infringement of its patent for Diflucan was...
To view the full article, register now.